Clinical Trial Update: Rifaximin-treatment of Collagenous Colitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for rifaximin in collagenous colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Collagenous Colitis

Drugs mentioned

• Rifaximin (rifaximin)

Snippet

Sponsor: Bonderup, Ole K., M.D. | Conditions: Collagenous Colitis | Phase 3 | Status: UNKNOWN